Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Sino Biopharmaceutical Ltd

+ Add to Watchlist

1177:HK

9.330 HKD 0.090 0.96%

As of 04:01:05 ET on 05/26/2015.

Snapshot for Sino Biopharmaceutical Ltd (1177)

Open: 9.520 Day's Range: 9.220 - 9.730 Volume: 10,430,076
Previous Close: 9.420 52wk Range: 5.950 - 10.760 1-Yr Rtn: +41.64%

Stock Chart for 1177

No chart data available.
  • 1177:HK 9.330
  • 1D
  • 1M
  • 1Y
9.420
Interactive 1177 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 1177

Current P/E Ratio (ttm) 29.1927
Estimated P/E(12/2015) 26.9653
Relative P/E vs. HSI 2.4587
Earnings Per Share (HKD) (ttm) 0.3196
Est. EPS (HKD) (12/2015) 0.3460
Est. PEG Ratio -
Market Cap (M HKD) 46,103.84
Shares Outstanding (M) 4,941.46
30 Day Average Volume 14,871,260
Price/Book (mrq) 6.6382
Price/Sale (ttm) 3.4935
Dividend Indicated Gross Yield 0.64%
Cash Dividend (HKD) 0.0150
Dividend Ex-Date 06/09/2015
5 Year Dividend Growth 11.63%
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 1177

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for 1177

Sino Biopharmaceutical Limited, through its subsidiaries, researches, develops, produces, and sells biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis.

Tse PingChairman/FounderCheng Cheung LingVice Chairman
Xu XiaoyangPresident/CEOYe Wei NongAsst President/Gen Mgr:R & D
More Company Profile & Key Executives for 1177

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil